For more information click here
SHL Telemedicine paid an additional NIS 2.6 million in indexation differentials and interest relating to the purchase price for the stake in Mediton and Medishur, pursuant to a court decision
Earlier from Shl Telemedicine
- SHL Telemedicine: completed the acquisition of an additional 27.5% of the shares in Mediton and the remaining 30% of the shares in Medishur
- SHL Telemedicine: announces invitation to a Special General Meeting and proposes “opting-out” from mandatory tender offer obligation
- SHL Telemedicine: receives District Court judgment in Israel regarding remaining 30% stake in Mediton and Medishur
- SHL Telemedicine: announces 2026 Annual General Meeting Results